CompaniesCombined Therapeutics

Combined Therapeutics

active

London, UK

Founded 2016

About

Oncolytic Virus Platform

Areas of Focus

Categories

Virus Technology

Team (18)

Asad Khanmohammed

Combined Therapeutics

Dan Anderson, Ph.D.

Combined Therapeutics

David Neafus, MBA

Combined Therapeutics

David Renauld, JD

Combined Therapeutics

Devenand Crease, Ph.D.

Combined Therapeutics

Ejiro Gbaje, MPH

Combined Therapeutics

View all 18 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

151

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

Today

Hover over trial bars to see details

Recent Trials

NCT06800196Lead Sponsor

A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations

PHASE1Not yet recruiting

151 participants

Started: Mar 31, 2025 · Completed: Dec 31, 2027

Funding History (1)

D

Dec 12, 2017

Locations (1)

Headquarters

London, UK

Map

Loading map...